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Abstract
Background: Dercum’s disease (DD) is characterised by obesity and chronic pain (> 3 months) in the adipose
tissue. The pathogenesis of DD is unknown, but inflammatory components have been proposed. In previous
reports and studies, an inconsistent picture of the histological appearance of the adipose tissue in DD has been
described. The aim of this investigation was to examine the histological appearance of adipose tissue in patients
with DD, with particular focus on inflammatory signs.
Methods: Fat biopsies were sampled from painful regions from 53 patients with DD. In 28 of the patients, a
control adipose tissue biopsy was taken from a location where the patient did not experience any pain. In
addition, fat biopsies were sampled from 41 healthy pain-free obese control patients and 11 healthy pain-free
normal weight control patients. The extent of inflammation was evaluated on histological sections stained with
haematoxylin-eosin.
Results: There was no statistically significant difference in the extent of inflammation between the biopsies from
the painful knee and the biopsies from the non-painful area (p = 0.5), nor between the biopsies from the
abdomen, and the biopsies from the non-painful area (p = 0.4), in patients with DD. A statistically significant
difference in extent of inflammation was observed between DD and obese control patients regarding the
abdomen (p = 0.022), but not the knee (p = 0.33). There were no differences in extent of inflammation between
DD patients and normal weight controls (p = 0.81).
Conclusion: The findings suggest that there is an inflammatory response in the adipose tissue in DD. However,
this response is not more pronounced than that in healthy obese controls. This contradicts inflammation as the
aetiology of DD.
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Background
Dercum’s disease (DD) is characterised by pronounced
pain in the adipose tissue and a number of associated
symptoms. The pain is chronic (for more than 3
months), symmetrical, often disabling [1] and resistant
to analgesics [2]. The pathogenesis of DD is unknown,
but inflammatory components have been proposed
[2-4]. However, laboratory markers for inflammation,
such as erythrocyte sedimentation rate (ESR) and C-
reactive protein (CRP), are usually normal in the condi-
tion [4-17]. However, a few studies have revealed that
some of the patients have elevated levels of CRP and
ESR. A study from 1937 of 112 women with DD,
reported that 66% had an ESR > 15 mm [18]. Moreover,
in a study by Herbst and Asare-Bediako [7], 33.4% of
the patients with DD had elevated CRP levels and 37.5%
elevated ESR levels. However, 38.2% of the patients
included in the study had autoimmune disease, such as
rheumatoid arthritis and lupus. In the same study 31.2%
of the patients had positive titres for antinuclear
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among the 38.2% that had an autoimmune disease. Case
reports have shown that markers for autoimmune dis-
ease, such as rheumatoid factor (RF), antinuclear antibo-
dies (ANA), anticardiolipin antibodies (ACA),
perinuclear anti-neutrophil cytoplasmic antibodies
(pANCA), cytoplasmic anti-neutrophil cytoplasmic anti-
bodies (cANCA) and antibodies against native DNA, are
commonly negative in DD [4,6,11,15]. Regarding blood
cytokines, a small study including 10 subjects and 5
controls [19] indicated that macrophage inflammatory
protein (MIP)-1b might be lower in patients with DD
than in normal controls. Moreover, a trend towards
higher levels of interleukin (IL)-13 and levels of fractalk-
ine were detected.
In previous reports and studies, an inconsistent pic-
ture of the histological appearance of the adipose tissue
in DD has been described. Fat biopsies in different case
reports have revealed histologically normal adipose tis-
sue without inflammation [8,10]. However, pathological
findings have been described in other studies. Dercum
originally considered the most interesting histological
finding to be interstitial inflammation of the nerves in
the adipose tissue of the painful sites [1,20], which has
only been confirmed in one case report [21].
As regards inflammatory signs in the adipose tissue in
DD, leukocytes and plasma cells have been detected in
two cases [3,22]. In addition, Herbst et al. [19] found
multi-nucleated giant (MNG) cells in three of the DD
patients (n = 5) and in none of the controls (n = 5).
Multi-nucleated giant cells are produced by activated,
pro-inflammatory macrophages. However, no differences
in number of macrophages could be seen between the
patients and the controls.
Other pathological findings in fat biopsies described in
DD are increased levels of connective tissue [19,23],
fibrolipoma with numerous embryonic vessels, [24],
reactive infiltration of fibrotic elements and small angio-
mas [25], granulomas [16] and capillary microthrombi
[26].
The aim of this investigation was to examine the his-
tological appearance of the adipose tissue in patients
with DD, with particular regard to inflammatory signs
in a larger series of patients, and compare them with
healthy, obese, body mass index (BMI)-matched controls
and controls with normal BMI.
Patients and Methods
Patients
A total of 53 women with adipose tissue pain were
recruited to the study. All patients were diagnosed and
referred to our clinic by the same consultant in internal
medicine. Diagnosis was based on a systematic physical
examination on three separate visits. The clinical criteria
of the disease used in this study were obesity (BMI >
28) and chronic pain (> 3 months) in the adipose tissue.
The disease can be classified as Type I (juxta-articular),
Type II (diffuse-generalised) and Type III (nodular) [2].
All of the patients included in this study had Type II
DD. As obese healthy controls, 41 healthy women of
similar age and BMI as the DD patients were recruited
from the patients operated on with abdominoplasty in
our clinic. None of the patients had had major weight
loss from bariatric surgery or medical weight loss that
could have affected the inflammatory variables. As nor-
mal weight healthy controls, 11 women with essentially
normal BMI (19 to 26) and of similar age as the DD
patients were recruited from the patients operated on
because of unilateral leg lymphoedema in our clinic.
Four had primary lymphoedema and seven secondary
lymphoedema following cancer treatment. The mean
duration of the lymphoedema was 16 years (median 15
(range 2-50) years). The patients with secondary lym-
phoedema had been clinically free from cancer for 15
years (median 14 (range 7-24) years) when the biopsies
were taken, and hence should not have any effect on the
inflammatory variables. The controls had no acute or
chronic pain. The patients and controls were given no
restriction in medication and no particular advice
regarding lifestyle. None of the patients was diagnosed
with any other disease that might give rise to an inflam-
matory reaction. The patients’ profile is given in Table
1. There were no differences between the DD patients
and the obese controls as regards age (p = 0.37), weight
(0.52) or BMI (p = 0.44). There was a difference
between the DD patients and the normal weight con-
trols as regards weight (p = 0.01) and BMI (p = 0.004),
but not age (p = 0.50). Similarly, there was a difference
between the obese controls and the normal weight con-
trols as regards weight (p = 0.001) and BMI (p = 0.042),
but not age (p = 0.37). The differences were analysed
using the Mann-Whitney test.
Fat biopsies
Fat biopsies, obtained by surgical biopsy, were sampled
from 53 women with DD. Biopsies were taken from
painful subcutaneous fat from the abdomen and the
knee region. In 28 cases, a control adipose tissue
biopsy was taken from a location where the patient did
not experience any pain, 21 from non-painful abdomen
and 7 from non-painful knee. Fat biopsies were also
sampled from the 41 obese control patients’ abdomen
a n dk n e er e g i o na n df r o mt h e1 1n o r m a lw e i g h tc o n -
trol patients’ knee region. All of the biopsies were
open surgical biopsies taken in the same way, measur-
ing about 15 × 15 mm.
There were no complications following the biopsies.
The biopsies were fixed and transported in a 4%
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Page 2 of 6formaldehyde medium and embedded in paraffin. Two
consecutive sections were cut from each biopsy and
stained with hematoxylin-eosin. The whole sections
were examined by the same pathologist (US) in a
blinded manner. The inflammatory reaction consisted of
lymphocytes, macrophages and possibly some fibro-
blasts. All the mentioned cells were diagnosed from
their appearance in the haematoxylin-eosin staining.
The cells were present in aggregates in the fatty tissue
as depicted in the figures. A few solitary lymphocytes
were also seen. The extent of the inflammatory reaction
was evaluated subjectively as described in Figures 1, 2
and 3, taking into consideration number of and size of
the inflammatory infiltrates. There is thus a continuum
of changes. The inflammatory reactions were given a
score between 0 and III, where 0 equalled no inflamma-
tion, I slight, II moderate and III pronounced inflamma-
tory reaction. For further explanation, see Figures 1, 2
and 3.
Laboratory tests
The erythrocyte sedimentation rate (ESR) was measured
using the Westergren method, that is 4 parts blood
were diluted with 1 part isotonic citric solution. The
level of sedimentation was measured after 1 hour. The
reference intervals for ESR for Swedish women are < 21
mm up to 50 years of age, and < 30 mm between 51
and 70 years of age [27].
Ethics
The study was approved by the Ethics of Human Inves-
tigation Committee at Lund University (LU 236-89, LU
422-91). All participants gave their written informed
consent to participate. The procedures were in accor-
dance with the Helsinki Declaration of 1964.
Statistics
Values are given as medians and ranges. Histograms
were drawn to examine the distribution of the measured
factors. The histograms indicated that the measured fac-
tors were not normally distributed. Differences in high-
est inflammatory reaction between biopsies from painful
locations and non-painful locations from DD patients
were analysed using paired McNemar’s test. Biopsies
taken from the painful knee region in DD patients were
compared to those from the knee region of control
patients, using chi-square tests. The same procedure
Table 1 Patient profile (median and range).
Baseline characteristics Dercum (n = 53) Obese controls (n = 41) Normal weight controls (n = 11)
Age (years) 51 (22-68) 50 (26-69) 43 (17-73)
Weight (kg) 95 (55-140) 91 (55-129) 69 (52-79)
BMI (kg/m
2) 35 (28-55) 34 (28-46) 24 (19-26)
There were no differences between the DD patients and the obese controls as regards age (p = 0.37), weight (0.52) or BMI (p = 0.44). There was a difference
between the DD patients and the normal weight controls as regards weight (p = 0.01) and BMI (p = 0.004), but not age (p = 0.50). Similarly, there was a
difference between the obese controls and the normal weight controls as regards weight (p = 0.001) and BMI (p = 0.042), but not age (p = 0.37). The differences
were analysed using Mann-Whitney test.
Figure 1 Low-power image of fat tissue from the knee with an
infiltrate of inflammatory cells. Haematoxylin-eosin staining. The
infiltrate is displayed at a higher magnification in Figure 2. The
photo was taken with a 10 × objective.
Figure 2 High-power image of Figure 1. Adipose tissue from the
knee. Haematoxylin-eosin staining. One infiltrate of this size and
only a few additional inflammatory cells gave a score of I. Two
infiltrates of this size gave a score of II. The photo was taken with a
40 × objective.
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Page 3 of 6was used for the abdomen. In all cases the highest score
for each biopsy was used when comparisons were made.
Differences in ESR between the DD patients and the
obese controls were analysed using the Mann Whitney
test.
Results
In the DD patients, 75% of the biopsies from painful
areas and 71% of the control biopsies from non-painful
areas (Table 2) demonstrated an inflammatory reaction
(I-III) with lymphocytes and macrophages (Figures 1, 2
and 3). An inflammatory reaction judged as I can be
seen in Figures 1 and 2 and II in Figure 3. In the obese
controls, 73% of the biopsies demonstrated an inflam-
matory reaction (I-III) and in the normal weighted con-
trols 45% of the biopsies demonstrated a slight
inflammatory reaction (I). Inflammatory reactions in adi-
pose tissue in all groups are summarised in Table 2.
Plasma cells were found in very few of the biopsies.
T h e r ew a sn od i f f e r e n c eb e t w e e na d i p o s et i s s u ef r o m
painful and non-painful abdomen (p = 0.4) or knee (p =
0.5).
Furthermore, no differences in extent of inflammation
were detected between DD and obese control patients
regarding the biopsies from the knee region (p = 0.33,
c
2 = 22.2, df = 20). A significant difference in extent of
inflammation was observed between DD patients and
obese controls patients for the biopsies from the abdo-
men (p = 0.022, c
2 = 29.3, df = 16).
There were no differences in extent of inflammation
between DD patients and normal weight controls (p =
0.81, c
2 = 6.1, df = 10) (knee). However, a difference
was detected between obese controls and normal weight
controls (p < 0.001, c
2 = 31.4, df = 8) (knee). The differ-
ences within and between the groups are summarised in
Table 2.
Among the DD patients of 50 years and younger, 26
patients had an ESR of < 21 mm and 2 patients > 21
mm (24 and 38 respectively) (median 11 mm (range, 4-
38)). Values were missing from three patients in the
younger age group. Among the DD patients over 50
years of age, all but one had an ESR of < 30 mm (med-
ian 9.5 (range 4-34)). The patient with a higher value
Figure 3 High-power image of fat tissue from the knee.
Haematoxylin-eosin staining. One infiltrate of this size, larger than
that in Figure 2, and a few additional inflammatory cells gave a
score of II. Three or more infiltrates of this size gave a score of III.
The photo was taken with a 40 × objective.
Table 2 Inflammatory reaction (score 0 to III) in fat biopsies and intra- and intergroup differences.
Group Biopsy Reaction
0 I II III
Dercum Painful abdomen (n = 41) 11 (27) 14 (34) 16 (39) -
Painful knee (n = 47) 11 (23) 21 (45) 14 (30) 1 (2)
Non-painful area (n = 28) 8 (29) 14 (50) 6 (21) -
Obese controls Abdomen (n = 41) 12 (29) 15 (37) 12 (29) 2 (5)
Knee (n = 41) 10 (24) 13 (32) 16 (39) 2 (5)
Normal weight controls Knee (n = 11) 6 (55) 5 (45) - -
Differences between groups (p-value)
Dercum vs. Obese controls - abdomen 0.022
Dercum vs. Obese controls - knee 0.33
Dercum vs. Normal weight controls - knee 0.81
Obese vs. Normal weight controls - knee < 0.001
Dercum - painful abdomen vs. Dercum - non-painful abdomen
1 0.4
Dercum - painful knee vs. Dercum - non-painful knee
2 0.5
1n = 21 pairs.
2n = 7 pairs. Figures within parenthesis depict percentage of total.
Number of patients (%). Differences in highest inflammatory reaction between biopsies from painful locations and non-painful locations from DD patients were
analysed using paired McNemar’s test. Biopsies taken from the painful knee region in DD patients were compared to those from the knee region of control
patients, using chi-square tests. The same procedure was used for the abdomen. In all cases the highest score for each biopsy was used when comparisons were
made.
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Page 4 of 6had an ESR of 34 mm. Values were missing from two
patients in the older age group. Among the obese con-
trol patients of 50 years and younger, all but two had an
ESR of < 21 mm, and two patients had values > 21 mm
(29 and 90 respectively) (median 11.5 (range 2-90)).
Values were missing from 5 patients in the younger age
group. Among the obese control patients over 50 years
of age, all but two patients had an ESR of > 30 mm
(median 15 (range, 1-41)). Values were missing from 8
patients in the older age group. There was no statistical
difference in ESR between the DD patients and the
obese controls, neither in the age group < 50 years (p =
0.99), nor in the age group > 50 years (p = 0.73).
Discussion
The strengths of the study are that the same consultant
diagnosed DD in all patients and that a control group of
healthy obese controls was included. Furthermore, no
study has been published with a greater number of
patients with DD examined through fat biopsies.
Studies in anatomical pathology as gold standard has
been challenged because of the difficulties in reproduci-
bility of histological diagnosis due to inter-observer var-
iation. This can be explained by the fact that
interpretive judgement and personal experience have to
be used by the pathologist to be able to make a histo-
pathological diagnosis [28]. However, in the present
study, the same pathologist judged all the fat biopsies in
a blinded fashion, and hence, such factors should be of
less influence. A limitation of the present study is that
we had no information on the use of over-the-counter
analgesics. It is possible that such drugs could have
affected the inflammatory reaction in the adipose tissue.
An inconsistent picture of the histological appearance
of the adipose tissue in DD has been reported in pre-
vious reports and studies. Recently, Herbst et al. [19]
found multinucleated giant cells in three patients with
this condition. However, when these patients were com-
pared with healthy obese controls, no differences in the
inflammatory reaction were seen. In this study, a differ-
ence in the inflammatory reaction in the adipose tissue
could be seen between patients with DD and healthy
obese controls comparing biopsies from the abdomen
but not from the knee. In recent years, research has sug-
gested that the adipose tissue in obesity elicits a chronic
low-grade inflammatory response that contributes to co-
morbidities such as diabetes, increased cardiovascular
risk and liver disease [29-31]. The expanded pool of adi-
pocytes is responsible for the increased production and
release of inflammatory mediators such as cytokines. An
increased density of macrophages has been observed in
the adipose tissue of obese subjects [31,32]. This can
explain why DD patients and weight-matched healthy
obese controls both have an elevated inflammatory
reaction and the presence of macrophages in the adi-
pose tissue.
In conclusion, our findings reveal that there is an
inflammatory response in the adipose tissue in DD.
However, this response might not be more pronounced
than that in healthy obese controls. This contradicts
inflammation as the aetiology of Dercum’s disease.
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